3d Diagnostic Imaging (LON:3DD) (LON: 3DD 0.6p/£1.45m)

3D Diagnostics, which owns the protected rights to a technology platform with a number of significant potential commercial products, announced interim results for the 6 months to 31 December 2011. Revenue suffered a significant drop to £67k (2010: £566k) whilst a slightly wider pretax loss of £987k (2010: £981k). Cash on the balance sheet has also fallen to £1.07m (2010: £2.02m). Whilst the results for the period were not positive, the Company stated that it now sees some early signs of an improvement in trading as a result of a number of initiatives it has put in place, such as the significant enhancement in product functionality, with all units in the field being successfully upgraded.

Angel Biotechnology (LON: ABH 0.21p/£6.96m)*

Angel announced that commissioning of the Cramlington facility is now complete as anticipated and that the plant is now available for development, technical transfer and other non-GMP (Good Manufacturing Practice) activities. Completion of recommissioning reflects a period of concerted effort by all staff from across the

business and their contractor WHP. Angel intends to utilise this facility to provide additional GMP manufacturing capabilities for the production of cell therapies, antibody purification and production of recombinant proteins. Central to this progress has been the on-going recruitment of local staff into positions in Quality, Validation and Operations functions. Work is underway to transfer pilot processes from the Pentlands facility as a necessary first step in securing their MHRA (Medicines and Healthcare products Regulatory Agency) licences. In addition to Cramlington activity the senior management team is evaluating commercial opportunities currently available to Angel.

Angle (LON:AGL) (LON: AGL 50.25p/£19.01m)

ANGLE, the technology commercialisation company, has reported further progress at its 33 per cent owned Geomerics, which specialises in computer games middleware. At the recent Game Developers Conference (GDC 2012) in San Francisco, Geomerics announced the development of new products for mobile devices and for Nintendo’s new WiiTM U console. These new products are expected to significantly expand the addressable market for Geomerics products. In partnership with ARM, Geomerics also showcased Enlighten running smoothly on a Samsung Galaxy Tab 7.7 tablet on the expo floor. This is an expansion of Geomerics’ product capability and Enlighten, via ARM CPU, now supports a wide range of mobile devices including the…

Unlock the rest of this article with a 14 day trial

or Unlock with your email

Already have an account?
Login here